< View All Healthcare Value Hub Articles

North Carolina Survey Respondents Worried about High Drug Costs; Support a Range of Government Solutions

State: North Carolina
Category: CHESS State Survey
Topic: Prescription Drugs

According to a survey of more than 1,400 North Carolina adults, conducted from October 18 to October 23, 2023, respondents are concerned about prescription drug costs and express a strong desire for policymakers to enact solutions.

More than half (58%) of survey respondents reported being somewhat or very worried about affording the cost of prescription drugs. Worry varied substantially by income group, with respondents in households making less than $50,000 per year1 experiencing the most worry (see Figure 1). However, it is important to note that households at all income levels reported high levels of worry.


NC_Rx_Brief_2023_Figure1.png

In addition to being worried about prescription drug affordability in the future, many North Carolina respondents have skipped, delayed, or avoided care altogether in the prior 12 months due to the cost. 1 in 3 respondents (33%) reported rationing medication by either not filling a prescription, cutting pills in half, or skipping a dose of medicine in the last year due to cost (see Figure 2).


NC_Rx_Brief_2023_Figure2.png

NC_Rx_Brief_2023_Table1.png

These hardships disproportionately impact people in lower-income households. As Table 1 shows, respondents living in households earning less than $50,000 and those earning between $50,000 and $75,000 per year reported higher rates of rationing their prescription medicines than respondents living in higher-income households. However, these hardships are alarmingly prevalent in middle-income households as well.

Respondents with North Carolina Medicaid coverage reported the highest rates of rationing medication compared to other insurance types, followed by those with private insurance. Finally, respondents living in households with a person with a disability reported notably higher rates of rationing medication due to cost in the past 12 months compared to respondents without a disabled household member (see Table 1).

Considering these prescription drug cost concerns—as well as concerns about high healthcare costs generally2—it is not surprising that North Carolina respondents were generally dissatisfied with the health system:

  • Just 30% agreed or strongly agreed that “we have a great healthcare system in the U.S.,”
  • While 75% agreed or strongly agreed that “the system needs to change.”

North Carolina respondents see a role for themselves in addressing prescription drug affordability. When asked about specific actions they could take:

  • 59% of respondents reported researching the cost of a drug beforehand, and
  • 80% said they would be willing to switch from a brand name to an equivalent generic drug if given the chance.

When given more than 20 options, the options cited most frequently as being a “major reason” for high healthcare costs were:

  • 77%—Drug companies charging too much money
  • 73%—Hospitals charging too much money
  • 70%—Insurance companies charging too much money

When it comes to tackling high drug costs, North Carolina respondents endorsed a number of prescription drug-related strategies:

  • 92%—Cap out-of-pocket costs for life-saving medications, such as insulin
  • 92%—Require drug companies to provide advanced notice of price increases and information to justify those increases
  • 91%—Authorize the Attorney General to take legal action to prevent price gouging or unfair prescription drug price hikes
  • 90%—Set standard prices for drugs to make them affordable
  • 90%—Create a Prescription Drug Affordability Board to examine the evidence and establish acceptable costs for drugs
  • 89%—Prohibit drug companies from charging more in the U.S. than abroad

Moreover, there is substantial support for government action on drug costs regardless of the respondent’s political affiliation (see Table 2).


NC_Rx_Brief_2023_Table2.png


Conclusion

The high burden of healthcare and prescription drug affordability, along with high levels of support for change, suggests that elected leaders and other stakeholders need to make addressing this consumer burden a top priority. Moreover, the COVID crisis has led state residents to take a hard look at how well health and public health systems are working for them, with strong support for a wide variety of actions. Annual surveys can help assess whether progress is being made.

Notes

  1. Median household income in North Carolina was $60,516 (2017-2021). U.S. Census, Quick Facts. Retrieved from: U.S.Census Bureau QuickFacts
  2. For more detailed information about healthcare affordability burdens facing North Carolina respondents, please see Healthcare Value Hub, North Carolina Residents Struggle to Afford High Healthcare Costs; Worry About Affording Healthcare in the Future; Support Government Action across Party Lines, Data Brief (December 2023).

Methodology

Altarum’s Consumer Healthcare Experience State Survey (CHESS) is designed to elicit respondents’ unbiased views on a wide range of health system issues, including confidence using the health system, financial burden and possible policy solutions.

This survey, conducted from October 18 to October 23, 2023, used a web panel from online survey company Dynata with a demographically balanced sample of approximately 1,500 respondents who live in North Carolina. Information about Dynata’s recruitment and compensation methods can be found here. The survey was conducted in English or Spanish and restricted to adults ages 18 and older. Respondents who finished the survey in less than half the median time were excluded from the final sample, leaving 1,455 cases for analysis. After those exclusions, the demographic composition of respondents was as follows, although not all demographic information has complete response rates:

NC_Rx_Brief_2023_Methodology.png

Percentages in the body of the brief are based on weighted values, while the data presented in the demographic table is unweighted. An explanation of weighted versus unweighted variables is available here. Altarum does not conduct statistical calculations on the significance of differences between groups in findings. Therefore, determinations that one group experienced a significantly different affordability burden than another should not be inferred. Rather, comparisons are for conversational purposes. The groups selected for this brief were selected by advocate partners in each state based on organizational/advocacy priorities. We do not report any estimates under N=100 and a co-efficient of
variance more than 0.30.

Appendix

NC_Affordability_Brief_2023_Appendix.png
Black BeltNon-RuralRural
Anson County, North CarolinaAlamance County, North CarolinaAlleghany County, North Carolina
Bertie County, North CarolinaAlexander County, North CarolinaAshe County, North Carolina
Bladen County, North CarolinaBrunswick County, North CarolinaAvery County, North Carolina
Columbus County, North CarolinaBuncombe County, North CarolinaBeaufort County, North Carolina
Cumberland County, North CarolinaBurke County, North CarolinaCamden County, North Carolina
Duplin County, North CarolinaCabarrus County, North CarolinaCarteret County, North Carolina
Edgecombe County, North CarolinaCaldwell County, North CarolinaCaswell County, North Carolina
Franklin County, North CarolinaCatawba County, North CarolinaCherokee County, North Carolina
Gates County, North CarolinaChatham County, North CarolinaChowan County, North Carolina
Granville County, North CarolinaCraven County, North CarolinaClay County, North Carolina
Greene County, North CarolinaCurrituck County, North CarolinaCleveland County, North Carolina
Halifax County, North CarolinaDavidson County, North CarolinaDare County, North Carolina
Hertford County, North CarolinaDavie County, North CarolinaGraham County, North Carolina
Hoke County, North CarolinaDurham County, North CarolinaHarnett County, North Carolina
Lenoir County, North CarolinaForsyth County, North CarolinaHyde County, North Carolina
Martin County, North CarolinaGaston County, North CarolinaJackson County, North Carolina
Nash County, North CarolinaGuilford County, North CarolinaLee County, North Carolina
Northampton County, North CarolinaHaywood County, North CarolinaMcDowell County, North Carolina
Pitt County, North CarolinaHenderson County, North CarolinaMacon County, North Carolina
Richmond County, North CarolinaIredell County, North CarolinaMitchell County, North Carolina
Robeson County, North CarolinaJohnston County, North CarolinaMontgomery County, North Carolina
Sampson County, North CarolinaJones County, North CarolinaMoore County, North Carolina
Scotland County, North CarolinaLincoln County, North CarolinaPasquotank County, North Carolina
Tyrrell County, North CarolinaMadison County, North CarolinaPerquimans County, North Carolina
Vance County, North CarolinaMecklenburg County, North CarolinaPolk County, North Carolina
Warren County, North CarolinaNew Hanover County, North CarolinaRutherford County, North Carolina
Washington County, North CarolinaOnslow County, North CarolinaStanly County, North Carolina
Wayne County, North CarolinaOrange County, North CarolinaSurry County, North Carolina
Wilson County, North CarolinaPamlico County, North CarolinaSwain County, North Carolina
 Pender County, North CarolinaTransylvania County, North Carolina
 Person County, North CarolinaWatauga County, North Carolina
 Randolph County, North CarolinaWilkes County, North Carolina
 Rockingham County, North CarolinaYancey County, North Carolina
 Rowan County, North Carolina 
 Stokes County, North Carolina 
 Union County, North Carolina 
 Wake County, North Carolina 
 Yadkin County, North Carolina 

Altarum in Action

Rhode Island Office of the Health Insurance Commissioner cites CHESS survey in letter to State House Committee on Health and Human Services about HB072 related to reimbursement rates and repealing affordability standards. Read more

Washington State Senator Patty Murray’s office cites the WA CHESS survey in press release about Senate Health, Education, Labor and Pensions (HELP) Committee hearing where Senator Murray questioned CEOs of major pharmaceutical companies about the high prices charged to Americans for their prescription drugs. Read more

Read More Altarum in Action Resources